Trademark: 76212606
Word

Status
Dead
Status Code
710
Status Date
Saturday, November 21, 2009
Serial Number
76212606
Registration Number
2706100
Registration Date
Tuesday, April 15, 2003
Mark Type
2000
Filing Date
Tuesday, February 20, 2001
Published for Opposition
Tuesday, January 21, 2003
Cancellation Date
Saturday, November 21, 2009

Trademark Owner History
CSL limited - Original Registrant

Classifications
5 Blood products, namely, plasma volume expanders, blood plasma, human albumin, blood clotting factors and immunoglobulins for medical and clinical use; pharmaceutical preparations derived from plasma and recombinant DNA technology for the prevention and/or treatment of blood disorders; products derived from recombinant DNA technology, namely, plasma volume expanders; human albumin, blood clotting factors and immunoglobulins for medical or clinical use
16 Printed matter and publications, namely, books, magazines, newsletters, brochures, leaflets and periodicals all featuring material in relation to pharmaceutical products, blood, blood products, bleeding disorders and blood fractionation; printed educational and teaching material in the field of pharmaceutical products, blood, blood products, bleeding disorders and blood fractionation; stationery; calendars and posters
40 Treatment of human biological products, namely, custom manufacturing and fractionation of blood, and transformation of blood products and products derived from blood and/or recombinant DNA technology

Trademark Events
Nov 21, 2009
Cancelled Sec. 8 (6-Yr)
Mar 17, 2008
Case File In Ticrs
Apr 15, 2003
Registered-Principal Register
Jan 21, 2003
Published For Opposition
Jan 1, 2003
Notice Of Publication
Nov 22, 2002
Sec. 1(B) Claim Deleted
May 13, 2002
Approved For Pub - Principal Register
Apr 23, 2002
Examiners Amendment Mailed
Feb 11, 2002
Final Refusal Mailed
Oct 15, 2001
Correspondence Received In Law Office
Aug 27, 2001
Correspondence Received In Law Office
Jun 18, 2001
Non-Final Action Mailed
Jun 15, 2001
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24